v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 23,398 $ 19,159
General and administrative 15,568 9,246
Depreciation and amortization 24 30
Total operating expenses 38,990 28,435
Loss from operations (38,990) (28,435)
Other income, net:    
Interest income, net 1,057 1,498
Foreign currency exchange gain (loss) (216) 60
Tax credit income 853 784
Change in fair value of royalty agreement derivative liability 12  
Loss on extinguishment of debt   (546)
Total other income, net 1,706 1,796
Net loss $ (37,284) $ (26,639)
Net loss per share:    
Basic $ (0.15) $ (0.12)
Diluted $ (0.15) $ (0.12)
Weighted-average common shares outstanding:    
Basic 253,280,551 216,146,934
Diluted 253,280,551 216,146,934
Other comprehensive income (loss):    
Gain (loss) on foreign currency translation $ (95) $ 272
Unrealized loss on short-term investments (247) (154)
Total comprehensive loss $ (37,626) $ (26,521)